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a b s t r a c t
Eukaryotic translation initiation factor eIF4B is necessary for ribosomal scanning through structured
mRNA leaders. In higher eukaryotes, eIF4B serves as a downstream effector of several signaling path-
ways. In response to mitogenic stimuli, eIF4B undergoes multiple phosphorylations which are thought to
regulate its activity. Recently, Ser422 was identiﬁed as a predominant site for human eIF4B phosphor-
ylation via several signaling pathways, and phosphomimetic amino acid substitutions S422D or S422E
were shown to activate eIF4B in living cells. However, stimulatory role of these modiﬁcations has never
been analyzed directly. Here, using both mammalian reconstituted translation initiation assay and
complete cell-free translation system, we perform a comparison of recombinant eIF4B derivatives with
the wild type recombinant protein, and do not ﬁnd any difference in their activities. On the contrary,
native eIF4B puriﬁed from HeLa cells reveals signiﬁcantly higher activity in both assays. Thus, the effects
of S422D and S422E substitutions on eIF4B activity in living cells observed previously either require some
other protein modiﬁcation(s), or may only be manifested in an intact cell. Our study raises the question
on whether the phosphorylation of Ser422 is sufﬁcient for eIF4B activation observed upon mitogenic
stimulation.
 2012 Elsevier Masson SAS. All rights reserved.
1. Introduction
In eukaryotic cell, protein synthesis is tightly regulated by post-
translational modiﬁcations of several components of translational
machinery. Concerted modulation of their activity provides a ﬂex-
ible response to extracellular stimuli [1,2]. Two most thoroughly
studied examples are Ser51 phosphorylation of eIF2 a subunit and
multiple modiﬁcations of eIF4E-binding proteins (of which the
most famous is 4E-BP1). The a subunit of the mammalian eIF2 is
phosphorylated by one of the four speciﬁc kinases which are acti-
vated upon various types of cell stress [3]. This leads to a rapid
sequestration of free eIF2 into “frozen” complexes with eIF2B,
a guanine nucleotide exchange factor, and dramatic reduction of
total protein synthesis in the cell. On the contrary, hierarchical
multiphosphorylation of 4E-BP1 at several Ser and Thr residues in
response to activation of mitogenic signaling pathways gradually
decreases afﬁnity of this inhibitor to cap-binding factor eIF4E, and
stimulates cap-dependent translation [4]. Beyond these two well
known cases, there are many other reports on post-translation
modiﬁcations that affect activities of translation initiation factors
in eukaryotic cells, although most of them are poorly characterized
(for review, see [1]).
Mammalian eIF4B is a 70 kDa protein containing two RNA-
binding domains [5,6]. This factor promotes binding of the 40S
ribosomal subunit to mRNA during translation initiation [7,8] by
direct stimulation of ATP-dependent RNA helicase activity of eIF4A
[9e12]. Although this stimulation is thought to constitute themajor
impact of eIF4B on translation, some other mechanisms of its action
may not be excluded. Apart from eIF4A and eIF4F, mammalian
eIF4B has been shown to directly interact with p170 subunit of eIF3
[13] and with poly(A)-binding protein PABP [14]. The factor is able
to bind two RNA molecules simultaneously [15] and forms a dimer
in solution [13,16]. One of its RNA binding domains has been
proposed to interact with the 18S rRNA [15], while the other one
may directly bindmRNA thus providing an additional contact of the
40S with the template [15,17], stabilizing the unwound mRNA in
a single-stranded conformation [11,18e20] or acting as a “pawl”
during unidirectional ribosomal scanning [21]. eIF4B has also eIF4F-
recycling activity allowing cap-binding complex to dissociate from
Abbreviations: eIF, eukaryotic initiation factor; HCV, Hepatitis C Virus; IRES,
Internal Ribosome Entry Site; 50 UTR, 50 untranslated region; Fluc, ﬁreﬂy luciferase;
Rluc, Renilla luciferase.
* Corresponding author. Tel.: þ7 495 9394857; fax: þ7 495 9393181.
E-mail address: dmitriev_sergey@genebee.msu.ru (S.E. Dmitriev).
Contents lists available at SciVerse ScienceDirect
Biochimie
journal homepage: www.elsevier .com/locate/b iochi
0300-9084/$ e see front matter  2012 Elsevier Masson SAS. All rights reserved.
http://dx.doi.org/10.1016/j.biochi.2012.06.021
Biochimie 94 (2012) 2484e2490
Author's personal copy
one mRNA and re-associate with another [22] and, in general, may
represent a kind of eIF4A ATPase activating protein needed also for
eIF4A removal from the scanning complex after ATP hydrolysis [23].
We have shown previously [24] that in a reconstituted
mammalian translation system eIF4B is absolutely required for the
48S complex formation with cap-dependent mRNAs that possess
even weak secondary structure containing GC pairs. Taking into
account that the majority of mammalian mRNAs have relatively
long (150e200 nt) leaders with a complex nucleotide composition
(see, for example [25],), these results unambiguously indicate that
eIF4B is a critically important translation machinery component.
Interestingly, a similar conclusion has been drawn recently in
another study using yeast translation reconstitution assay [26],
despite the fact that yeast mRNAs in general have much simpler
leaders [27].
The importance of eIF4B for overall cellular translation efﬁ-
ciency was further corroborated by ﬁndings that its inactivation
during mitosis (mediated by binding to 14-3-3s [28]) and its
cleavage upon induction of apoptosis [14,29] are well correlated
with reduction of protein synthesis in cell. Modulation of eIF4B
activity by phosphorylation (see below) is also relentlessly
accompanied by changes in general translation level (for review,
see [30,31]). Finally, siRNA-mediated depletion of eIF4B in
mammalian cells [32] or knockout of TIF3 gene that encodes eIF4B
in yeast [33,34] both cause defects in protein synthesis, disrupting
general and mRNA-speciﬁc translational control.
Interestingly, in our previous study we found that eIF4B puriﬁed
from HeLa cells possessed signiﬁcantly higher activity in the reac-
tionof 48S translation initiation complexassembly thanabacterially
expressed protein [24]. It was proposed that the cause of such
a difference could be a post-translational modiﬁcation(s) [24,35].
Indeed, large-scale proteomic approaches revealed more than 40
sites of modiﬁcations in the human eIF4B, mostly phosphorylation
of Ser, Thr and Tyr, but also acetylation of Lys (summarized in HPRD
database [36], see http://www.hprd.org). Since 1980s, eIF4B has
been well documented to be multiphosphorylated in both
mammalian and plant systems [35,37e45], and in the former case,
the twomajor sites of themodiﬁcationhavebeen identiﬁed. In2004,
Raught et al. determined Ser422 as a site of eIF4B phosphorylation in
response to stimulation of human HEK293 cells by serum [35], and
later, Peng with colleagues [46] and van Gorp et al. [44] found an
additional mitogen-regulated site, Ser406. The both sites lie within
one of the two RNA-binding domains of eIF4B and are well
conserved among vertebrates (Fig. S1).
Ser422 is regarded as the major modiﬁcation site that is phos-
phorylated in response to amino-acid refeeding [44] and treatment
of serum-starved cells with mitogens such as insulin, epidermal
growth factor or phorbol ester PMA [35,44,47e51], or cytokines like
IL-3, IFNa, IFNg or IFNl [44,52,53]. Ser422 phosphorylation is also
increased in response to DNA-damaging agents [54] or during
arsenic-induced cell transformation [55], and it also accompanies
some virus infections [56,57]. Depending on the conditions, the
phosphorylation may be directed by either p70S6K1/2 via PI3K/
mTOR signaling pathway [35], p90RSK1/2 via MAPK cascade
[49,52,53] or directly by PKB/Akt [44]. The main pathways involved
in eIF4B Ser422 phosphorylation are represented in Fig. 1.
Recently, two amino acid substitutions that mimic Ser422
phosphorylation (S422D and S422E) were reported to enhance
eIF4B afﬁnity to the eIF3 complex [49,51] and positively affect
expression of reporter cap-dependent mRNAs [51] when eIF4B wt,
eIF4B S422D or eIF4B S422E were overexpressed in cultured
mammalian cells. In contrast, the mutant eIF4B S422A produced no
effect on translation in such anassay [35,44,51]. In the latter case, the
non-phosphorylatable protein synthesized in vivo might acquire
a low activity similar to the recombinant (non-phosphorylated)
protein that we used before in our assay of 48S initiation complex
assembly in vitro [24]. This suggestion led us to perform a compar-
ison of the recombinant wt and phosphomimetic S422D and S422E
proteins activity in the reaction of 48S reconstitution from puriﬁed
components. Here we show that the S422D and S422E eIF4B
derivatives have the same activity in this assay as the wt protein,
which was lower than the activity of a native eIF4B protein puriﬁed
from HeLa cells. The same results were obtained also in a complete
cell lysate.Ourdata suggest that Ser422phosphorylationmaybenot
sufﬁcient for eIF4B activation observed in mammalian cells upon
mitogenic stimulation.
2. Materials and methods
2.1. Plasmid constructs and in vitro transcription
Plasmid pET3b-4B for expression of recombinant humanwt eIF4B
without any tag in E. coli [58] was kindly provided by W. Merrick
(CWRU, Cleveland, Ohio). S422D and S422E substitutions were
introduced by PCR-directed mutagenesis with oligonucletide GAGT-
CATCACAAACTGGGACC as a forward primer and ATCTCCTGTCCTC-
GACCGTTCC or TTCTCCTGTCCTCGACCGTTCC as reverse ones,
respectively. ORF correctness in all three constructswas conﬁrmedby
sequencing of the complete coding regions. Plasmid encoded for TPL-
b-globin fusion mRNA (TbG) was described earlier [24]. For in vitro
transcription, theplasmidwas linearizedbydigestionat theEcoRI site
located downstream to primer annealing place, and RiboMAX kit
(Promega) was used. The resulting uncapped transcripts were
precipitated with 2 M LiCl, and then ScriptCap Capping System (EPI-
CENTRE Biotechnologies) was used to obtain m7G capped transcript,
followed by another LiCl precipitation. Plasmids coded for ﬁreﬂy
luciferase directed byeitherHCV IRESorhumanb-actin, LINE-1, Apaf-
1 or c-myc 50 UTRs were described earlier [59,60]. b-actin-Rluc
constructwasobtainedby inserting thehumanb-actin50 UTR into the
pRluc plasmid [59]. For plasmid CAAcI-Fluc preparation, the
GA(CAA)5GAA leader was fused to a coding region of the cIlacZ
leaderless construct [61] by PCR with primers CCCATGGTAA-
TACGACTCACTATAGACAACAACAACAACAAGAAATGAGCACAAAAAA-
GAAACC and GTGGGATCCTCAAGCTGCACTTGTGTTAATG, and the
resulting fragment was digested with NcoI and inserted into pGL3
Fig. 1. Signaling pathways involved in phosphorylation of eIF4B Ser422. Kinases that
directly phosphorylate Ser422 are double outlined. The main axis of the Ras/MEK/ERK
and PI3K/Akt/mTOR pathways are highlighted by thick arrows and dark grey ovals.
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vector (Promega). To obtain luciferase encoding mRNAs used for
in vitro translation, PCR products were ﬁrst synthesized from each
construct, with the same reverse primer (T50AACTTGTTTATTG-
CAGCTTATAATGG) that introduced a 50 nt long 30 poly(A) tail, and
speciﬁc T7 promoter containing forward primers (for details, see
[59,60,62]). The transcription was performed as described above,
except thateitherARCAorApppGcapanalog (both fromNewEngland
Biolabs) were added into reaction mixture in 5:1 excess to GTP, to
perform co-transcriptional capping of the cap-dependent or HCV
messages, respectively.
2.2. Puriﬁcation of translation initiation components
eIF2, eIF3, eIF4F, 40S and60Swerepuriﬁed fromHeLa cell extract,
eIF1, eIF1A and eIF4A were expressed in E. coli and puriﬁed as
described [24,63e65]. Puriﬁed tRNAfMet, a kind gift from V. Makhno
and Y. Semenkov, was used as initiator tRNA. For aminoacylation,
recombinant MetRSase was used [65]. Native human eIF4B was
puriﬁed from HeLa extract according to [24]. For preparation of
recombinant eIF4B proteins, E. coli Rosetta strain was used. Over-
night culturewas diluted 1:20, grown at 37 C up to A600 1.0 and the
gene expression was induced by 0.5 mM IPTG. Cell were grown
further for 4 h at 30 C, harvested and disrupted by ultrasonic in
A100 buffer (20 mM TriseHCl pH 7.5, 100 mM KCl, 10% glycerol and
1mMDTT). Then KCl concentrationwas elevated to 0.5M, the lysate
was incubated in ice for 30 min, and debris was precipitated. The
cleared lysate was diluted with A100 buffer to decrease KCl
concentration and fractionated by ion-exchange chromatography at
phosphocellulose. Proteins eluted at 250e500 mM were collected,
dialyzed against the same buffer containing 150mMKCl, and loaded
ontoMonoQ5/5 FPLC column.WhenKCl gradient 150e500mMwas
applied, eIF4B was eluted around 300 mM KCl. It was concentrated
with AmiconUltra (Millipore), and KCl concentration were
lowered to 100 mM by dilution with the same buffer containing
50 mM KCl.
2.3. Assembly and analysis of translation initiation complexes
48S ribosomal complexes were assembled and analyzed by toe-
printing assay as described earlier [24,66]. Brieﬂy, 48S complexes
were assembled by incubating 0.5 pmol of mRNA for 10 min at
30 C in a 20-ml reaction volume that contained the reconstitution
buffer (20 mM TriseHCl pH 7.5, 110 mM KOAc, 2.5 mM Mg(OAc)2,
0.25 mM spermidine-HCl, 1 mM DTT), 0.4 mM GTP and 1 mM ATP,
10 pmol of Met-tRNAfMet, 2.5 pmol of 40S ribosomal subunits and
combination of factors (eIF1 (10 pmol), eIF1A (10 pmol), eIF2
(5 pmol), eIF3 (5 pmol), eIF4A (10 pmol), eIF4F (2 pmol) and various
amount of eIF4B, as described in the text). For toe-printing, 50
terminally [32P]-labeled oligonucleotide 50 TCACCACCAACTTCTTC-
CAC 30 was used. Assembled complexes were analyzed directly by
primer extension using AMV RT (Promega) essentially as described
[66]. The autoradiogram was obtained with Phosphorimager
(Molecular Dynamics) and quantitatively analyzed by ImageQuant
software (GE Healthcare).
2.4. Krebs-2 cells S30 extract and in vitro translation
S30 extracts were prepared as described in [62]. Translation
experiments were performed in a total volume of 10 ml, which
contained 3.5 ml of the S30 extract, translation buffer (20 mM
Hepes-KOH pH 7.6, 1 mM DTT, 0.5 mM spermidine-HCl,
0.6 mM Mg(CH3COO)2, 8 mM creatine phosphate, 1 mM ATP,
0.2 mM GTP, 100 mM KCH3COO and 25 mM of each amino acid), 2 u
of RiboLock RNase inhibitor (Fermentas), equimolar mixture of
reporter mRNAs (totally 0.5 pmol) encoded for Fluc and Rluc under
control of various leaders, and 2 ml of eIF4B or A100 buffer, as
indicated. The translation mixture was incubated at 30 C for 1 h.
The luciferase activities were measured using the Dual Luciferase
Assay kit (Promega).
3. Results
3.1. eIF4B wt, S422D and S422E are equally active in 48S
reconstitution assay
To analyze effects of the amino acid substitutions that mimic
Ser422 phosphorylation, on eIF4B activity in vitro, we obtained four
different preparations of the human factor (Fig. 2A). Three of them
(wt, S422D and S422E) were recombinant proteins produced in E.
coli. To avoid any side effect brought about by terminal extensions,
we used untagged constructs and puriﬁed the proteins by ion-
exchange and FPCL chromatography (see Materials and Methods).
The fourth preparation was native eIF4B obtained from HeLa cell
extract with the use of a standard procedure [24], with the last two
stages being the same as in the case of the recombinant prepara-
tions. We used the native protein as a positive control throughout
out study, since earlier we showed the signiﬁcantly higher activity
of such preparation in the 48S initiation complex reconstitution
assay [24].
It has been shown that the substitutions S422D and S422E
positively affected eIF4B activity when these eIF4B mutants were
overexpressed in cultured cells [35,51], most probably by
increasing its interaction with eIF3 [49,51,53]. The latter suggests
that such eIF4B variants stimulate protein biosynthesis in cell by
direct enhancement of translation initiation complex formation
[51]. To test this possibility, we performed a comparison of the four
eIF4B variants for their activity in the reaction of 48S complex
reconstitution from puriﬁed components with a model mRNA that
harbors rather long and GC-rich 50 UTR. We took the same mRNA
(TbG) as we had used before in such an assay since it was known to
require elevated amount of eIF4B for efﬁcient 48S assembly [24].
The mRNA possessed 200 nt long tripartite leader of late adeno-
virus transcripts fused to the rabbit b-globin mRNA (Fig. 2B).
In our initial experiment, we used a concentration of eIF4B
proteins that had been stated as a standard one for our assay [24]
(10 mg/ml, w150 nM) which corresponds to w6:1 molar ratio of
eIF4B to mRNA. The initiation complexes were visualized by toe-
printing technique [24,63,66]. The results shown in Fig. 2C
conﬁrm our previous observation that eIF4B is absolutely required
for 48S assembly with this mRNA (compare lines 1 and 2e5) and
clearly demonstrate that all three recombinant proteins direct the
complex formation with similar efﬁciency (compare lines 2, 3 and
4). This result indicates that amino acid substitutions S422D and
S422E do not affect eIF4B activity in this test. In contrast, the native
protein did stimulate 48S complex formation more efﬁciently than
any recombinant eIF4B variants (Fig. 2C, line 5). To exclude the
possibility that this difference is speciﬁc for the concentration of
the factor we used, we performed the same comparison along the
wide range of eIF4B concentration (Fig. 2D). An effect of the amino
acid substitutions could not be observed in any case, whereas the
native protein clearly possessed signiﬁcantly higher activity in the
whole range of eIF4B concentration tested.
These results suggest that the recombinant eIF4Bs lacked either
a proper protein folding or an activating post-translational modi-
ﬁcation. In the latter case, the negative result might suggest that the
amino acid substitutions S422D and S422E do not reproduce such
amodiﬁcation. However, the alternative explanation does exist that
the stimulating effect of phosphomimetic substitutions observed
in vivo requires additional component(s) lacking in our recon-
stituted system.
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3.2. eIF4B wt, S422D and S422E stimulate translation in a complete
cell lysate to the same extent
To exclude the latter possibility, we analyzed effects of the
amino acid substitution on eIF4B activity in a cell-free translation
system based on a complete cell extract. First, to develop proper
experimental conditions, we used a mix of two reporter mRNAs,
one of which encoded the ﬁreﬂy luciferase (Fluc) under control of
the hepatitis C virus (HCV) internal ribosome entry site (IRES),
while the other containedm7G-capped 50 UTR of the human b-actin
mRNA and encoded Renilla luciferase (Rluc). We expected that
addition of eIF4B would stimulate the b-actin mRNA translation,
whereas the Fluc luciferase synthesis directed by the HCV IRES
would remain at the same level.
In our hands, addition of any of our eIF4B preparations into the
conventional rabbit reticulocyte lysate (RRL) inhibited cap-
dependent translation (data not shown). This was not completely
unexpected, since RRL had long been known as an inadequate
system for studying translation initiation mechanisms (see, for
example [62,67],). The same effect of translation repression by
eIF4B added into RRL has been observed also by Raught et al. [35]
Therefore, in all experiments below we used a cell-free system
based on Krebs-2 ascite cells extract, which more closely repro-
duces the situation in living cells [60,62].
In this in vitro system, the recombinant wt eIF4B selectively
stimulated translation of the capped mRNA possessing the human
b-actin leader (Fig. 3A) while the HCV IRES-directed translationwas
even slightly inhibited (most likely due to a competition with
endogenous cap-dependent mRNAs present in the lysate). The
stimulation effect was reproduced also with several other cap-
dependent mRNAs (Fig. 3B). Curiously, in this assay we did not
observe any direct correlation of stimulation degree with a level of
50 UTR secondary structure. Although in the case of an extremely
long (906 nt) and GC-rich leader of the human retrotransposon
LINE-1 mRNA the degree of translation stimulation by eIF4B was
among the highest, the level of stimulation for mRNA containing
Fig. 2. Activity of the different eIF4B preparations in the 48S reconstitution assay. (A) SDS-PAGE of the four different preparation of the human eIF4B used in the study. (B)
Schematic representation of the TPL-b-globin fusion (TbG) mRNA. A part of the 50 UTR that corresponds to the b-globin leader is represented by the thick line, coding region is
shown as the white box. (C) Toe-printing analysis of the 48S initiation complex reconstituted on the TbG mRNA with different eIF4B preparations. In line 1, no eIF4B was added.
Sequencing lanes obtained with the same primer and the corresponding cDNA are shown on the right. (D) Efﬁciency of the 48S complex assembly on the TbG mRNA at various eIF4B
concentrations as revealed by toe-printing. The volumes were obtained by quantiﬁcation of the toe-print band intensities and dividing them to total intensity in the corresponding
lanes. All the experiments were performed in triplicate, with one representative result shown for each case in panels (C) and (D).
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the b-actin leader (84 nt long) were close to that of Apaf-1 50 UTR
(577 nt) directed mRNA and even higher than that of c-myc 50 UTR
(410 nt) directed one (Fig. 3B). Moreover, the translation of mRNA
possessing (CAA)5 leader which most likely possesses a single-
stranded conformation was stimulated to even a higher extent
than that of the LINE-150 UTR-directedmRNA. The latter was all the
more unexpected as mRNAs with the (CAA)n leaders have been
shown to possess a relaxed dependence of eIF4 factors and do not
require eIF4B for translation initiation in the 48S reconstitution
system [68]. These observations may suggest that eIF4B function in
translation initiation is not limited to assistance in unwinding RNA
secondary structure of the leader.
Nevertheless, it should be noted that all cap-dependent mRNAs
we tested were stimulated by eIF4B. We therefore examined effects
produced by the different eIF4B forms on translation of the Renilla
luciferase mRNAwith the b-actin 50 UTR. As evident from Fig. 3C, all
three recombinant proteins stimulated the cap-dependent mRNA
translation to the same extent, while the native eIF4B had signiﬁ-
cantly (w1.5 times) higher activity in this assay. This clearly
demonstrates that S422D or S422E is not enough to reproduce the
effect of the native protein in the whole cell lysate as well, and
excludes the possibility that some unknown cytosolic factor is
needed to mediate the stimulatory effect of phosphomimetic
Ser422 substitutions observed in vivo.
4. Discussion
Human eIF4B has long been known to be a phosphoprotein (for
review, see [31]). Several signaling cascades converge on eIF4B
phosphorylation, thus underlining its importance in cell response
to various stimuli (see Fig. 1). Recently, several groups presented
solid evidence that phosphorylation of eIF4B at Ser422 signiﬁcantly
enhances cap-dependent translation in cultured cells by a mecha-
nism that involves modulation of eIF4B afﬁnity to the eIF3 complex
[44,49,51,53]. According to these data, eIF4B phosphomimetic
mutants S422D and S422E were able to reproduce the effects of
eIF4B phosphorylation in cultured mammalian cells.
To uncover details of the underlying mechanism, we decided to
analyze the activity of eIF4B variants in the system of 48S complex
reconstitution from puriﬁed components [24]. Since homogeneous
preparations of differentially phosphorylated recombinant eIF4B
molecules could not be obtained in vitro due to an excess of
potential modiﬁcation sites in the protein [69], we used the phos-
phomimetic mutants S422D and S422E in our analysis.
Previously, in our in vitro system we observed superiority in
activity of the eIF4B puriﬁed form HeLa cells over the bacterially
expressed protein [24]. In the present study, we conﬁrmed this
observation. However, all the recombinant eIF4B variants (wt,
S422D and S422E) turned out to have the same relatively low
activity in the assay (Fig. 2).
Since manifestation of the eIF4B phosphomimetic mutations
might require some additional component(s) lacking in our
reconstituted system, we performed an analysis of their effects on
eIF4B activity in the complete cell-free system based on Krebs-2
ascite cell extract [60,62]. In these tests, no difference between
the recombinant eIF4B variants were observed as well, although
the native eIF4B protein still demonstrated signiﬁcantly higher
activity (Fig. 3).
From these results, one could propose one of the following
possibilities. First, S422D and S422E may have not any stimulatory
role in eIF4B activity, while the effects reported previously for
cultured cells reﬂected some unrelated events (like elevated eIF4B
expression or improved protein stability). Although eIF4B puriﬁed
from HeLa cells nevertheless showed the superior effect even
in vitro, this could be explained simply by its better folding. It
Fig. 3. Effect of different eIF4B preparations on in vitro translation in the complete cell
lysate. (A) Differential effect of eIF4B on cap-dependent vs. HCV IRES-dependent trans-
lation. Capped Renilla luciferase mRNA driven by the human b-actin 50 UTR (Actin-Rluc)
and the HCV IRES-directed ﬁreﬂy luciferase mRNA (HCV-Fluc) were translated in the
presence of increasing amount of the recombinant eIF4B wt protein. Luciferase activity
values were normalized to the values obtained in the absence of exogenous eIF4B. (B)
Stimulation of cap-dependent translation of ﬁreﬂy luciferase mRNAs with different
leaders byaddition of the recombinant eIF4Bwt protein (20 mg/ml). (C) Differential effect
of eIF4B preparations on in vitro translation of the Actin-Rluc mRNA.
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should be noted, however, that the complete cell lysate we used for
in vitro translation should possess all molecular chaperones needed
for re-folding of cytosolic proteins during the 1 h long incubation of
the reaction mixture. For this reason, we suggested the ﬁrst
explanation unlikely. However, the higher activity of the native
protein may also be explained by some other modiﬁcation(s) of
eIF4B that stimulate its activity independently on phosphorylation
of Ser422 (see below). The corresponding modiﬁcation enzymes
activity could be lost during the lysate preparation since many of
signaling pathway components are membrane bound proteins.
Then, the effects of S422D and S422E mutations on global
protein synthesis observed in vivo could be mediated by some
secondary effects. eIF4B phosphorylation at Ser422 may be
required for speciﬁc activity of the initiation factor toward a certain
set of mRNA species. As is clear from our experiments in cell-free
translation system (Fig. 3B), the stimulation provided by eIF4B is
different for different mRNAs. The phosphorylated factor (or cor-
responding eIF4B mutants) could have higher activity toward some
speciﬁc RNA secondary structures located within leaders of
a speciﬁc set of mRNA species. Thus, being overexpressed in
cultured cells it can stimulate production of some regulatory
proteins (e.g. components of translational apparatus) which in turn
leads to stimulation of global protein synthesis. Such secondary
effects could not be analyzed in a cell-free system.
The third explanation is that manifestation of S422D or S422E
effects requires some conditions that are only present in intact
living cells. These might be speciﬁc protein localization to intra-
cellular compartments, interaction with the cytoskeleton or other
conditions which are absent from in vitro systems, even from the
complete cell lysate. In this case, superiority of the native protein
over the three recombinant preparations in our systems may be
explained by some other unrelatedmodiﬁcations, as in theﬁrst case.
Finally, S422D and S422E may have not any effect on eIF4B
activity, until some other, prerequisite modiﬁcation is applied.
Again, such a modiﬁcation could be present in the native eIF4B
preparation.
Thus, our study raises the question on whether the phosphor-
ylation of Ser422 is the sufﬁcient modiﬁcation for eIF4B activation
observed in cultured human cells uponmitogenic stimulation, or at
least whether its effect is direct. It is important to note that in the
very ﬁrst study where this particular modiﬁcation was determined
[35], at least one other phosphorylation at Ser was detected that
was not dependent on the stimulation by serum. This phosphory-
lationwas not reproduced in vitro by S6K1 treatment. This, or some
other modiﬁcation, could be an indispensable condition for the
manifestation of Ser422 phosphorylation effects, or even a prereq-
uisite event for it, being a part of a hierarchical phosphorylation
scheme similar to that known for 4E-BP1 (for review, see [4,70]).
For example, Ser406 was recently determined as a novel major
mitogen-regulated phosphorylation site which induction upon
insulin treatment was dependent on both MEK and mTOR activity
[44]. Ser406 has also been shown to be phosphorylated by pro-
proliferative and pro-survival protein kinase Pim-2 that is
thought to regulate the cell cycle in an mTOR independent manner
[46]. Interestingly, S406A substitution abrogates stimulatory effect
of eIF4B overexpression in vivo similarly to S422A [44]. Although in
early work [35] Ser406 was shown to be dispensable for phos-
phorylation of both Ser422 and the other site (the abovementioned
undetermined, serum-independent one), it may nevertheless play
an important role in manifestation of their effects in vivo. Similarly,
phosphorylation of eIF4B at several additional positions by cell
cycle regulated kinase Plk1 that was observed upon arsenic treat-
ment [45], along with many other eIF4B modiﬁcations that were
found in large-scale proteomic surveys (see http://www.hprd.org)
could play a role in eIF4B activation and its modulation by Ser422
phosphorylation. These questions require additional studies that
should involve both in vivo and in vitro analysis.
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